AUGUST 31: NZ HERALD: Otago University biomedical researchers have been awarded a $950,000 Health Research Council Grant for a three-year project to investigate the likely role of a protein, activin C, in promoting prostate cancer growth. READ MORE>
AUGUST 31: NZ HERALD: He’s a doctor who has written a book on prostate cancer, he’s built a wellness retreat at Abel Tasman National Park and his hobbies include nutrition. READ MORE>
AUGUST 31: YAHOO XTRA NEWS: Researchers searching for a cure for obesity have developed a drug that not only makes mice lose weight, but reverses diabetes, lowers their cholesterol, has effects on prostate cancer cells – something that may help explain links between prostate cancer and obesity. READ MORE>
AUGUST 31: NZ DOCTOR: Restrictions on access to intravenous prostate cancer treatment drug Zoladex (goserelin) will be lifted tomorrow in an agreement that sees Pharmac continuing to fully subsidise the drug. As part of the same agreement with manufacturer AstraZeneca, a special authority will no longer be required for the drug, which will have subsidy and delisting protection until June 30, 2013. READ MORE>
AUGUST 31: SUNDAY HERALD (SCOTLAND): Suspicions are growing about the prostate cancer medical evidence used to justify the release of the man convicted of the Lockerbie bombing. READ MORE>
AUGUST 30: SHAKOPEE VALLEY NEWS: A $2 million, 16-wheel mobile unit with leather seats, computers, flat-screen televisions and state-of-the-art medical technology is being used to bring medical testing to American Indian populations in Minnesota. READ MORE>
AUGUST 30: PSA RISING.COM: A potential anti-cancer agent called ZD4054 is being tested in clinical trials around the world in patients with prostate cancer to see if it can block the uptake of endothelin A and thereby shrink tumors or slow their progression. READ MORE>
AUGUST 30: STRAIGHT FURROW: Australia will go it alone next month when it begins the mandatory fortification of bread-making flour with synthetic folate, considered a possible prostate cancer risk by some researchers. READ MORE>
AUGUST 30: URO TODAY: Degarelix, a recently approved LHRH antagonist, has been shown to work more quickly in lowering serum testosterone levels, with acceptable safety and a mechanism that avoids the testosterone surges associated with LHRH agonist use. READ MORE>
AUGUST 30: SCIENCE DAILY: The mainstay immune system protein TRAF6 plays an unexpected, key role activating a cell signaling molecule that in mutant form is associated with prostate and other cancer growth, researchers at the University of Texas report. READ MORE>
AUGUST 30: CANCER CONSULTANTS.COM: A drug treatment called Bonefos (sodium clodronate) – that blocks the function of the cells which reabsorb bone – reduces the risk of death by 23% in men with metastatic prostate cancer, report UK researchers. READ MORE>
AUGUST 30: ABC NEWS HEALTH: Men with prostate cancer are being diagnosed at a younger age and earlier stage today than in years past, and the racial disparity in stage at diagnosis has decreased significantly, says a report in the Journal of the National Cancer Institute. READ MORE>
AUGUST 30: NEW YORK TIMES: The death of Senator Edward Kennedy from a brain tumour is a reminder that relatively little progress has been made in the cancer death rate in four decades, despite the many billions spent on research. READ MORE>
AUGUST 30: URO TODAY: A study of US prostate patients prior to 1999 and those treated since then shows major improvements in early diagnosis and treatment success rates. READ MORE>
AUGUST 30: URO TODAY: A gene fusion common in cancer patients called TMPRSS2-ERG is associated with worse prognosis in men with prostate cancer, Harvard Medical School researchers have found, with higher tumor stage and tumor-specific death or metastasis. READ MORE>
AUGUST 30: URO TODAY: Prostate patients who carry a gene mutation found in families with breast cancer will more often have high risk prostate cancer, with a higher death rate. READ MORE>
AUGUST 30: URO TODAY: Even patients with lymph node positive prostate cancer should undergo radical prostatectomy, new research has found. READ MORE>
AUGUST 30: URO TODAY: Australian researchers have identified a novel transcription factor in metastatic prostate cancer designated IV07, which appears to be involved in the regulation and co-ordination of multiple cancer promoting pathways. READ MORE>
AUGUST 29: PROSTABLOG NZ: Blue September got off to a roar – literally – at Kaiwharawhara Placemakers in Wellington today – thanks to the throaty sounds of a Cobra sports car. READ MORE>
AUGUST 29: NEW PROSTATE CANCER INFOLINK: A new way to test negative biopsy samples to see if in fact prostate cancer is present will be tested on 500 US volunteers. READ MORE>
AUGUST 28: URO TODAY: Whether or not prostate cancer patients have a partner makes no difference to baseline physical or mental health, but partnered participants have less bowel bother and a lower fear of recurrence than those without partners. READ MORE>
UGUST 28: URO TODAY: Analysis of nearly 100 websites dealing with radical prostatectomy showed the accuracy of information pertaining to sexual health is poor, with many making false statements about the long-term outcomes for erectile function. READ MORE>
AUGUST 28: URO TODAY: The use of ejaculate as the medium for detecting prostate cancer has a number of advantages compared with post-prostatic massage. READ MORE>
AUGUST 28: MANUKAU COURIER: Cobra cars, Harley Davidson motorbikes and blue-dressed Mainfreight trucks will blast into Manukau this Sunday to launch the Prostate Cancer Foundation’s Blue September. READ MORE>
AUGUST 27: PROSTABLOG NZ: The NZ Parliamentary inquiry into prostate cancer screening and testing will hear submissions on September 16 and 23. The Prostate Cancer Foundation’s president, Barry Young, will give his evidence on September 23.
AUGUST 27: HERALD.IE (Dublin): Men are still unwilling to talk about prostate cancer, despite its prevalence in Irish society and massive awareness campaigns, a cancer survivor has warned. READ MORE>
AUGUST 27: URO TODAY: A new study supports combining the use of oral phosphodiesterase type 5 inhibitors (PDE5i – eg: tadalafil) with a vacuum erection device in men in whom PDE5i alone failed. READ MORE>
AUGUST 27: URO TODAY: Guidelines on “watchful waiting” or “active surveillance” as options for those diagnosed with prostate cancer reflect a changed attitude toward in the light of the early detection of these tumours and the data now available regarding active surveillance. READ MORE>
AUGUST 27: NORTH COUNTY TIMES: Some medical groups are developing what they call “decision aids” to cancer screening and testing, plain-English guides that give equal voice to the advantages and disadvantages of options and include real patients explaining why they chose differently. READ MORE>
AUGUST 27: URO TODAY: The majority of prostate cancer patients with a bouncing PSA after treatment with intensity-modulated radiotherapy remain biochemically and clinically free of disease with extended follow-up. READ MORE>
AUGUST 27: URO TODAY: The risk of dying of a second cancer within 10 years after radical prostatectomy is 4.1%, lower than that of prostate cancer (5.4%), according to German researchers. READ MORE>
AUGUST 27: URO TODAY: Prostate size does not appear to affect biochemical recurrence after radical prostatectomy. However, estimated blood loss and operation time increased with larger prostate size, and positive surgical margins are more often observed in smaller glands. READ MORE>
AUGUST 26: SEO PRESS RELEASES: A US businessman is launching a nationwide tour to inform corporations, chambers of commerce, golfing communities, economic clubs, universities and other interested civic organisations to be proactive about prostate cancer. READ MORE>
AUGUST 26: SCHWITZER HEALTH NEWS BLOG: It’s wrong to use a network television platform to give one-sided advice to an entire population of men without giving balancing information on harms. READ MORE>
AUGUST 26: CANCER CONSULTANTS: Clodronate reduces the risk of death by 23% in men with metastatic prostate cancer, according to the results of a study published in The Lancet Oncology. Clodronate belongs to a class of drugs called bisphosphonates, which are used to treat or prevent bone complications. READ MORE>
AUGUST 26: SCIENCE BLOG: Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or along with radiation therapy for treatment of prostate cancer have an associated increased risk of death. READ MORE>
AUGUST 26: EXAMINER.COM: Reports of Bernie Madoff’s terminal prostate cancer appear to be highly exaggerated, perhaps another scheme on the master schemer’s part to generate sympathy among inmates or the general public. READ MORE>
AUGUST 26: BOSTON CHANNEL.COM: No matter the shortcomings of the popular PSA test, it is still is a valuable tool that has contributed to the US’s declining death rate from prostate cancer in the last few years. READ MORE>
AUGUST 26: URO TODAY: Men older than 70 are more likely to have larger and higher grade prostate cancer than younger men, according to an autopsy study of men with no history of prostate cancer. READ MORE>
AUGUST 26: URO TODAY: There is little difference in the outcome from open or laparoscopic radical prostatectomy, a study of about 200 US patients shows. READ MORE>
AUGUST 26: URO TODAY: Use of a retrourethral transobturator sling after radicial prostatectomy for prostate cancer is a highly successful treatment for incontinence, Australian researchers have found. READ MORE>
AUGUST 26: STUFF: Blue September seems to have arrived early in Wellington, if this photo is anything to go by. READ MORE>
AUGUST 25: Schwitzer health news blog: The Larry King Live programme on prostate cancer became another celebrity-filled promotion and, thus, was terribly one-sided and incomplete. READ MORE>
AUGUST 25: PSA RISING: An extract of the Chinese herb Wedelia (a member of the sunflower family of plants) shrinks the androgen receptor and prostate cancer in mice, according to a study published in Clinical Cancer Research. READ MORE>
AUGUST 25: USA TODAY: Cyclist Lance Armstrong has put his money where his mouth is when it comes to supporting cancer research. READ MORE>
AUGUST 25: URO TODAY: High-dose radiotherapy is superior to conventional-dose radiotherapy in preventing biochemical failure, according to new research, suggesting that this should be offered as a treatment for all patients, regardless of their risk status. READ MORE>
AUGUST 25: PR WEB: A combination of brachytherapy and intensity modulation radiation therapy can cure between 98% for low-risk patients, 95% for intermediate risk and 85% for high risk patients in expert hands,” says a prostate cancer specialist with the Florida Radiation Oncology Group. READ MORE>
AUGUST 24: ONCOLOGY STAT: Researchers have identified four clinical risk factors that reduce the likelihood of achieving a 30%-or-greater decline in serum PSA during the three months after the start of chemotherapy. READ MORE>
AUGUST 24: BLOGGING WOMEN: Partners of men who have prostate cancer often have a hard time getting advice and support. Now there’s a website specifically designed to help, called hisprostatecancer.com READ MORE>
AUGUST 24: I-HEALTH BULLETIN NEWS: Elevated insulin levels in the normal range appear to be associated with an increased risk of prostate cancer, according to a new study published in the Journal of the National Cancer Institute. READ MORE>
AUGUST 24: NEW PROSTATE CANCER INFOLINK: A table showing the chances of cancer returning after cryotherapy (freezing) treatment of prostate cancer has been calculated by researchers who looked at about 2500 cases. READ MORE>
AUGUST 23: URO TODAY: Many of the men in a study of the after effects of prostate cancer had insomnia and depression with a moderate level of distress. READ MORE>
AUGUST 23: PROSTABLOG NZ: While it was a good watch for those of us with a direct interest in prostate cancer, last night’s Larry King Live special programme failed to tackle some of the real issues about the disease. READ MORE>
AUGUST 22: NEW PROSTATE CANCER INFOLINK: Interpretation of biopsy sample slides by pathologists has played a significant role in a Gleason score “shift” over the past 15 years, according to a new study. However, there are some questions over some of the researchers’ conclusions. READ MORE>
AUGUST 22: NEW PROSTATE CANCER INFOLINK: A technique called electoporation being used to inject a new DNA vaccine into prostate cancer patients is another example of the ways in which clinical scientists are exploring new treatment opportunities. READ MORE>
AUGUST 22: WCVBTV5: Researchers are optimistic about Provenge, a new way of treating prostate cancer that would help the body’s own immune system to attack tumors once they have developed. Researchers at a number of institutions, including Beth Israel Deaconess Medical Center, are working on similar vaccine treatments. READ MORE>
AUGUST 22: URO TODAY: Enzymes in the prostate that promote aggressive cancer growth need to be suppressed and a study looks at the success of new drugs now available to do the job. READ MORE>
AUGUST 22: CANCERFACTS.COM: Patients who experience fatigue during radiotherapy for prostate cancer may be reacting to activation of a network of cells and proteins called cytokines, which produce an inflammatory response. READ MORE>
AUGUST 22: PROSTABLOG NZ: Usually, the global prostate cancer community welcomes its heroes, mostly celebrities and politicians who announce they have the disease and plan to fight it. But the latest prominent sufferer is probably not doing a great deal for the cause. READ MORE>
AUGUST 22: URO TODAY: British researchers have reviewed the literature on incontinence related to prostate cancer and its treatment, as urinary incontinence is known to have a significant impact on health-related quality of life. READ MORE>
AUGUST 22: URO TODAY: Prostate cancer tumors that have spread to the bones can be inhibited by targeting the bone and its micro-environment rather than the tumor alone. READ MORE>
AUGUST 22: PUB MED: Limitations of the prostate-specific antigen test have led to variations designed to improve its accuracy (eg: age- and race-specific cutoffs, free prostate-specific antigen tests) – however, none of these modifications has been widely adopted because of unclear benefits. READ MORE>
AUGUST 22: URO TODAY: Thalidomide and similar drugs are being assessed as powerful ways to inhibit tumour growth and spread once chemotherapy stopes working on advanced prostate cancer patients. READ MORE>
AUGUST 22: PROSTABLOG NZ: US Prostate Cancer Foundation founder and chairman Mike Milken is joined by former Secretary of State Colin Powell, LA Dodgers manager Joe Torre, former tennis great John McEnroe and computer engineering professor Christopher Rose on a Larry King Live special focusing on prostate cancer. READ MORE>
AUGUST 21: PROSTABLOG NZ: The NZ government needs to add prostate cancer to its health priorities, if a Prostablog poll is any indication. READ MORE>
AUGUST 21: NEW PROSTATE CANCER INFOLINK: There are no sound data to support the effectiveness of “metabolic” therapies that are designed to remove “toxins” from the body through bowel purging and a healthy diet, and plenty of data about the potential side effects (up to and including death). READ MORE>
AUGUST 21: SCIENCE DAILY: Researchers have destroyed prostate cancer tumors in mice by injecting them with specially-coated, miniscule carbon tubes and then superheating the tubes with a brief zap of a laser. READ MORE>
AUGUST 21: CANCER CONSULTANTS.COM: Men who wish to increase their odds of retaining sexual function might be counselled to choose external beam radiation therapy over cryo-ablation, according to Canadian research. READ MORE>
AUGUST 21: URO TODAY: Physical activity effectively attenuates many of the side effects of androgen deprivation therapy and should be recommended to prostate survivors as an alternate therapy. READ MORE>
AUGUST 20: NEW PROSTATE CANCER INFOLINK: The UK’s Ministry of Health is committing to the broader availability of proton beam radiation therapy – despite the treatment’s unproven record so far. READ MORE>
AUGUST 20: WORLD VILLAGE.COM: The Westernised diet of red meat and saturated fat is thought to significantly contribute to the probability of an individual developing prostate cancer. A prostate cancer nutrition diet should be started as early on in life as possible. READ MORE>
AUGUST 20: RENAL AND UROLOGY NEWS.COM: Researchers have identified a new genetic marker that may be associated with earlier time for diagnosis of prostate cancer in Caucasian men who have a family history of the disease. If the data are confirmed, the marker could help clinicians personalise prostate cancer screening. READ MORE>
AUGUST 20: NEW ENGLAND JOURNAL OF MEDICINE: A new drug just approved by the FDA for high risk prostate cancer patients suffering bone loss has performed well in a trial. READ MORE>
AUGUST 20: EXAMINER.COM: The number of botched cancer treatment cases at Philadelphia’s Veterans Association hospital continues to rise as a recent review found six more. READ MORE>
AUGUST 20: PROSTATE NATURAL REMEDIES.COM: Firmagona (degarelix for injection), a new injectable prostate cancer medication for the treatment of advanced prostate cancer, is now available in the US. READ MORE>
AUGUST 20: URO TODAY: Docetaxel plus estramustine chemotherapy represents an active and well-tolerated treatment for Japanese hormone-refractory prostate cancer patients. READ MORE>
AUGUST 20: URO TODAY: Obesity is not associated with increased risk of lymph node metastases in men undergoing radical prostatectomy and extended pelvic lymph node dissection. READ MORE>
AUGUST 20: URO TODAY: Researchers have developed an accurate tool to determine the chances of finding prostate cancer in men who have already had a negative biopsy andfor whom a repeat biopsy is being considered. READ MORE>
AUGUST 20: URO TODAY: The heaviest smokers in a study of more than 20,000 had a 24% to 30% greater risk of death from prostate cancer than non-smokers. READ MORE>
AUGUST 20: URO TODAY: Low telomeric DNA content – a measure of genomic instability – found in prostate biopsy tissue predicts early likelihood of post-prostatectomy PSA recurrence, a study has found. READ MORE>
AUGUST 20: BIO-MEDICINE: The first patients have entered a Phase 2 clinical trial of a innovative targeted drug treatment, Aptocine(TM) (talaporfin sodium), for benign prostatic hyperplasia (enlarged prostate). READ MORE>
AUGUST 20: SUBMIT YOUR ARTICLE.COM: Men need to do more to look after what goes on inside their bodies, not just what’s obvious on the outside. READ MORE>
AUGUST 19: PROSTABLOG NZ: While many Kiwis probably still associate prostate cancer fund-raising with moustaches and men growing them each November, our main prostate cancer group no longer gets money from that source. READ MORE>
AUGUST 19: ABC BRISBANE: It seems Australian men still aren’t getting the message about prostate health - so a new, federally funded programme is relying on volunteer ‘health ambassadors’ to urge men in their local communities to make regular visits to their GPs. READ MORE>
AUGUST 19: SAN FRANCISCO SENTINEL: Compounds found in cannabis may help combat prostate cancer, Spanish research shows – but an expert from Britain’s leading cancer research charity said the early results did not justify getting high on cannabis. READ MORE>
AUGUST 19: NZ HERALD: Fisher & Paykel Appliances chief executive John Bongard says he has been grappling with prostate cancer for the past year and will leave the business at the end of the year. READ MORE>
AUGUST 19: REUTERS: Dendreon Corp says it expects quick success for its Provenge prostate cancer treatment if it is approved by US regulators, with initial demand for the world’s first cancer vaccine exceeding supply. READ MORE>
AUGUST 19: URO TODAY EDITORIAL: Recent publication of very early results from the two big randonmised trials of PSA screening has fueled a shift in the pendulum of cancer detection policy towards the notion that public health may somehow be better served by avoiding the diagnosis and treatment of prostate cancer altogether. READ MORE>
AUGUST 19: URO TODAY: Heavy, daily drinking increases the risk of high-grade prostate cancer, and heavy drinking makes finasteride ineffective for reducing prostate cancer risk, a study shows. READ MORE>
AUGUST 19: URO TODAY: The UK National Institute for Health and Clinical Excellence guidance recommends conservative management of men with ‘low-risk’ localised prostate cancer, monitoring the disease using changes to PSA over time and re-biopsy. However, there is little evidence of the changes in PSA level that should alert to the need for clinical re-assessment. READ MORE>
AUGUST 18: GUARDIAN: “My brothers in malignancy have shared their experiences with generous candour,” writes globally known media blogger Jeff Jarvis in his new Guardian prostate cancer column. READ MORE>
AUGUST 18: BIZ FACE FORUM: A new look at a large database of prostate cancer patients shows that obesity plays no favourites when it comes to increasing the risk of recurrence after surgery. Being way overweight is equally bad for blacks and whites, say researchers. READ MORE>
AUGUST 18: URO TODAY: Fragmentation of a prostate biopsy core can potentially distort analysis of the cancer’s extent and aggressiveness, a new study has confirmed. READ MORE>
AUGUST 18: MEDICAL NEWS TODAY: Time of surgery, median PSA level, year of surgery and non-nerve sparing surgical technique are significant predictors of bladder neck contracture after radical prostatectomy, British research has found. READ MORE>
AUGUST 18: MEDICAL NEWS TODAY: A novel genetic mechanism that may govern an individual’s risk of developing prostate cancer has been identified by researchers at the University of Southern California. READ MORE>
AUGUST 18: NEW YORK TIMES: Researchers have discovered a way to identify drugs that can specifically attack and kill cancer stem cells, a finding that could lead to a new generation of anti-cancer medicines and a new strategy of treatment. READ MORE>
AUGUST 18: USA TODAY: Screening programmes for breast, prostate and colon cancer are starting to bear fruit in the US, say researchers who have analysed America’s dropping cancer death rates. READ MORE>
AUGUST 17: PROSTABLOG NZ: The NZ parliamentary inquiry into prostate cancer closes off its submissions this Friday. READ MORE>
AUGUST 16: OTAGO DAILY TIMES: A protein found in the prostate gland could hold the key to developing a more accurate screening test for prostate disease, University of Otago researchers say. READ MORE>
AUGUST 16: URO TODAY: Early erectile function rehab with Viagra after nerve-sparing radical prostatectomy showed good results in 90% of patients examined in a Spanish study. READ MORE>
AUGUST 16: ONCOLOGY STAT: Researchers have identified four clinical risk factors that reduce the likelihood of achieving a 30%-or-greater decline in serum prostate-specific antigen during the 3 months after the start of chemotherapy. READ MORE>
AUGUST 16: NEW PROSTATE CANCER INFOLINK: Prostate Cancer International has started a series of 5-minute video interviews with opinion-makers in the world of prostate cancer, from respected clinicians to activists and support group organizers. Click here to see any of the initial eight videos.
AUGUST 16: URO TODAY: Short-term urinary side effects after prostate brachytherapy are common, follow a predictable course, and typically resolve within one year, a new study concludes. READ MORE>
NEW YORK TIMES: Denosumab, a new drug to prevent fractures in men undergoing prostate cancer hormone treatment, is likely to get FDA approval for high risk cases only. READ MORE>
AUGUST 16: PROSTABLOG NZ: John has now moved to the stage of needing chemotherapy for his advanced prostate cancer, but the government-subsidised version in NZ has been surpassed by a more effective drug – at $5000 a dose. That’s way beyond Mary’s bank balance. READ MORE>
AUGUST 16: URO TODAY: The outcomes of robot-assisted radical prostatectomy in elderly men are largely comparable to those in younger men, with the exception of higher pathological Gleason grade, a transient delay in return of continence, and taking longer to return to driving after surgery. READ MORE>
AUGUST 16: URO TODAY: The medical costs of prostate cancer have been calculated by Canadian researchers using data from more than 40,000 patients, with the conclusion that diagnosis and death stages are the most expensive. READ MORE>
AUGUST 16: URO TODAY: Swedish research shows a new treatment for advanced prostate cancer, the gonadotrophin-releasing hormone antagonist/receptor blocker Degarelix, is well tolerated, with no systemic allergic reactions. READ MORE>
AUGUST 16: CN MONEY.COM: Since the mid-1990s, US death rates for prostate cancer have fallen well below those of other countries, but life expectancy has suffered because of smoking and obesity. READ MORE>
AUGUST 15: ADVANCED PROSTATE CANCER: A new drug has shown promise in prolonging life and reducing pain for men with advanced prostate cancer and for whom chemotherapy in not working. READ MORE>
AUGUST 15: MEDIC MAGIC: The debate on the effectiveness of complementary treatments, alternative therapies and natural cures for prostate cancer is ongoing. READ MORE>
AUGUST 15: URO TODAY: The more Viagra a man takes, the greater the likelihood of side effects like headaches, “flushing”, dyspepsia and problems with sight. READ MORE>
AUGUST 13: MEDICAL NEWS TODAY: A public survey conducted in Europe found that the vast majority of people overestimate the life-saving benefits of breast and prostate cancer screening, according to a new study published in the Journal of the National Cancer Institute. READ MORE>
AUGUST 13: NEW PROSTATE CANCER INFOLINK: New data published in the New England Journal of Medicine clearly suggests that bone-loss drug denosumab has a significant effect compared to placebo in men with prostate cancer. READ MORE
AUGUST 13: AFTERCANCERNOWWHAT.COM: The wives of men with prostate cancer tend to worry more about the cancer recurring than the patients themselves, say researchers at the Mount Sinai Medical Center in the US. READ MORE>
AUGUST 13: PUGET SOUND BUSINESS JOURNAL: The US drug company that is about to produce the world’s most promising immuno-therapy prostate cancer treatment – Provenge - has reported a second-quarter loss of $126.7 million. READ MORE>
AUGUST 13: NEWSWITHVIEWS.COM: Any man not wanting prostate cancer in the first place or who is treating this problem should spend some time understanding at least the basics of the androgen receptor. READ MORE>
AUGUST 13: CANCER FACTS.COM: A new drug injected twice a year reduced the risk of vertebral fractures by 62% compared to placebo in men with prostate cancer being treated with hormone blockade therapy, a new study shows. READ MORE>
AUGUST 13: URO TODAY: Earlier evidence that brassicas - cabbage, broccoli, brussels sprouts, etc – reduce prostate cancer risks has been enhanced by a recent study of more than 11,000 men in Germany. READ MORE>
AUGUST 12: E-CANCER MEDICAL SCIENCE: Oral bone loss drug sodium clodronate improves overall survival in men with advanced prostate cancer, but does not reduce the risk of death in men with localised disease, according to trial results published in The Lancet Oncology. READ MORE>
AUGUST 12: BUZZ MACHINE: Top journalist blogger Jeff Jarvis is now blogging on a different topic – his recent discovery he has prostate cancer. READ MORE>
AUGUST 12: STL-TODAY.COM: In recent years, a small but growing number of men with prostate cancer have opted for another treatment choice – holding their collective breath. READ MORE>
AUGUST 12: PRESS ASSOC, UK: A Twitter campaign has been aiding an awareness drive on prostate cancer in the UK. READ MORE>
AUGUST 12: URO TODAY: On average, men with local prostate cancer consult about five separate sources of information before treatment, according to a new US study. READ MORE>
AUGUST 12: URO TODAY: The five-year survival rate for prostate cancer patients differs according to age at diagnosis, increasing from 70% in men age under 55 years at diagnosis to 83% in men age over 65 years, according to a French study. READ MORE>
AUGUST 12: URO TODAY: Biopsies are not particularly useful in determining how laterally widespread or close to the margins tumours are in prostate cancer patients. READ MORE>
AUGUST 12: URO TODAY: Israeli doctors have successfuly experimented with a biodegradable inflatable balloon that is inserted in a prostate cancer patient to shield adjacent tissues from external beam radiation. READ MORE>
AUGUST 11: NEW PROSTATE CANCER INFOLINK: A new set of guidelines for prostate cancer screening has been issued by the US National Comprehensive Cancer Network. NCCN has laid out an argument based on the concept that PSA testing is effective and needs to be more rigorously conducted in high-risk populations. READ MORE>
AUGUST 11: NEW PROSTATE CANCER INFOLINK: A screening test that distinguishes between indolent and harmful prostate cancer, better drugs, and more immuno-therapy treatments (like Provenge) for advanced cancer – these are priorities the prostate community has chosen in a poll. READ MORE>
AUGUST 11: URO TODAY: Combined treatment for advanced prostate cancer gives better results than a single treatment, new research shows. READ MORE>
AUGUST 11: URO TODAY: Aspirin appears to lower PSA levels in some men, according to US researchers, who say “PSA was 9% lower in aspirin v non-aspirin users, after adjusting for age, race, family history biopsy outcomes and enlarged prostate treatments. READ MORE>
AUGUST 11: URO TODAY: The end-fire transrectal ultrasound probe improves biopsy detection rate of prostate cancer compared to the side-fire probe. READ MORE>
AUGUST 10: DAILY MAIL: There is growing scientific evidence that strongly suggests diets rich in certain foods can help prevent prostate cancer and its spread. This includes detailed advice on diet that helps or hinders: READ MORE>
AUGUST 10: PHILADELPHIA INQUIRER: It turned out to be a questionable move when the Philadelphia Veterans Association Medical Center decided in the late 1990s to start providing a popular prostate cancer therapy, and turned to its longtime, distinguished partner in medicine – the University of Pennsylvania. READ MORE>
AUGUST 9: SAN ANTONIO HEALTH: Two US national studies taking place in San Antonio are focusing on watchful waiting and aim to give men more definitive answers as they consider the trade-offs between the anxiety of living with prostate cancer and the well-known side effects of surgery and radiation. READ MORE>
AUGUST 9: URO TODAY: Obese men undergoing radical prostatectomy are found to have more aggressive prostate cancers, a new study finds. READ MORE>
AUGUST 9: URO TODAY: A major obstacle in understanding the biology of advanced prostate cancer is clinicians’ limited ability to obtain metastatic tissue for study. READ MORE>
AUGUST 9: URO TODAY: A better definition of biochemical failure, improved imaging techniques, and accurate specimen mapping are needed to diagnose the return of cancer more quickly after treatment like radiotherapy. READ MORE>
AUGUST 9: URO TODAY: A number of promising new drugs and treatments targeting prostate cancer progression are in clinical trials and have the potential to provide novel treatment options for advanced cancer in the near future. READ MORE>
AUGUST 9: URO TODAY: Smoking is likely to be a risk factor for prostate cancer progression and should be relevant in prostate cancer research and prevention of death. READ MORE>
AUGUST 9: URO TODAY: The dual inhibition of both types 1 and 2 of the testosterone-reducing enzyme 5-AR with the new drug dutasteride may prove more useful than another commonly used drug, finasteride, in treating prostate cancer. READ MORE>
AUGUST 8: URO TODAY: Placement of zoledronic acid-releasing testicular prostheses has the potential to become the preferred clinical management tool for prostate cancer patients with bone metasthases after bilateral orchiectomy. READ MORE>
AUGUST 8: NUTRA-INGREDIENTS.COM: Enhancing bioactive content of tomatoes and broccoli may enhance efficacy in the prevention of prostate cancer, according to new research. READ MORE>
AUGUST 8: HEALTHY FELLOW.COM: There is considerable excitement about the potential of soy in the prevention and treatment of prostate cancer. READ MORE>
AUGUST 7: NEW PROSTATE CANCER INFOLINK: A “novel pharmacologically regulated dendritic cell vaccine” for treating patients with advanced prostate cancer is being trialled by a US company. READ MORE>
AUGUST 7: URO TODAY: Quality of life two years after treatment for prostate cancer shows wide variability, according to a new study in Spain. READ MORE>
AUGUST 7: URO TODAY: Zinc may serve an important role in regulating cell growth and apoptosis (the process of programmed cell death) in prostate cancer. READ MORE>
AUGUST 6: URO TODAY: A pollen extract (Cernilton) tested on German men with prostatitis/chronic pelvic pain syndrome significantly improved total symptoms, pain, and quality of life without severe side-effects. READ MORE>
AUGUST 6: MEDICAL NEWS TODAY: The US Food and Drug Administration (FDA) has approved the trade name FIRMAGON (degarelix for injection) for its prostate cancer treatment previously marketed under the generic name degarelix. READ MORE>
AUGUST 6: CHICAGO TRIBUNE: A chemical in grapefruit juice has been shown to boost the effects of anti-cancer drugs and assist with treatments of prostate and other cancers. READ MORE>
AUGUST 6: MSNBC: The value of a widespread prostate cancer screening is questioned by the top medical officer for the American Cancer Society. READ MORE>
AUGUST 6: URO TODAY: A high vitamin B-6 intake may improve prostate cancer survival among men with a diagnosis of localised-stage disease, according to a Swedish study. Folate, riboflavin, vitamin B-12, and methionine intakes were not associated with prostate cancer survival. READ MORE>
AUGUST 6: URO TODAY: General and mental health levels in brachytherapy patients were inferior to those in radical prostatectomy patients in a Japanese comparative study. READ MORE>
AUGUST 6: URO TODAY: Research into the anatomy and physiology of the male continence mechanism has enabled surgeons to propose innovative surgical techniques during radical prostatectomy for preventing incontinence. READ MORE>
AUGUST 6: URO TODAY: Tallness is associated with increased risk for younger onset aggressive prostate cancer, according to a large prospective prostate cancer screening trial in the US. READ MORE>
AUGUST 5: URO TODAY: Patients with hormone-resistant advanced prostate cancer have good prospects for receiving substantial benefit with the addition of chemotherapy, a Greek study has found. READ MORE>
AUGUST 5: NEW YORK TIMES: As more people with cancer survive and try to return to their former lives, a side effect of chemotherapy is getting more and more attention. Its name is apt, if unappealing: chemo brain. READ MORE>
AUGUST 5: PHILADELPHIA INQUIRER: CyberKnife radiosurgery – which uses narrow beams of radiation to kill several types of cancer – is marketed as a less invasive, more convenient way to treat prostate cancer, a pitch that has proved convincing for about 3000 men over the last six years. But some prostate-cancer experts have reservations. READ MORE>
AUGUST 5: WALL ST JOURNAL: “Decison aids” to help people decide on the best treatment for diseases like prostate cancer have been developed by the Foundation for Informed Medical Decision Making, which grew out of research at Dartmouth University in New Hampshire, US. READ MORE>
AUGUST 5: NEW PROSTATE CANCER INFOLINK: Two studies published recently add some additional information to our understanding of prostate cancer risk assessment in specific groups of patients. READ MORE>
AUGUST 5: MEDICAL NEWS TODAY: Age doesn’t make a difference in the long-term therapeutic outcomes of treating prostate cancer, a new study by scientists has found. READ MORE>
AUGUST 5: AMERICAN CANCER SOCIETY: In an effort to resolve confusion about what men need to be told about prostate cancer screening, the American College of Physicians has published advice to GPs about what they should advise patients. READ MORE>
AUGUST 4: PHILADELPHIA INQUIRER: The debate about expensive new treatments for prostate cancer pits doctor against doctor and raises tough questions about when insurance should pay for promising techniques, especially when technology is a key driver of rising costs. READ MORE>
AUGUST 4: NEW YORK TIMES: One reason the US war on cancer – declared in the 70s by President Nixon – has stalled is a lack of cancer patients volunteering for treatments trials. READ MORE>
AUGUST 4: URO TODAY: The role of chronic prostatitis resulting from chlamydia trachomatis in male fertility decrease has been examined in a new study, highlighting probable damage to germinal cells. READ MORE>
AUGUST 4: FOOD CONSUMER: Exposure to sunlight may help reduce risk of prostate cancer, according to a new review article in International Journal of Cancer. READ MORE>
AUGUST 4: URO TODAY: A new UK study may have implications on understanding pathways of prostate cancer progression and on identifying potential targets for screening – pending further investigation of associations between PSA testing, Gleason score, and cancer stage. READ MORE>
AUGUST 4: URO TODAY: Androgen deprivation therapy for prostate cancer has adverse side effects like reduced bone mass and increased risk for fracture, reduced lean mass and muscle strength, mood disturbance and increased fat mass. An Australian investigation has examined the effects of long term exercise on reversing musculoskeletal-related side effects, and cardiovascular and diabetes risk factors in men receiving androgen deprivation. READ MORE>
AUGUST 3: URO TODAY: An understanding of the mechanisms prostate cancer cells use to bypass androgen-deprived conditions, thus moving patients to the hormone refractory stage, is the aim of a new Dutch study. READ MORE>
AUGUST 3: NATURAL NEWS: A higher dietary intake of omega-3 fatty acids may protect men from prostate cancer even if they have a genetic predisposition to the disease, researchers have found. READ MORE>
AUGUST 2: PROSTABLOG NZ: A leading NZ scientist has discovered a novel compound he believes will suppress the prostate cancer that is killing him. READ MORE>
AUGUST 2: LOS ANGELES TIMES: Long considered just a supplement consumed with calcium for bone health, vitamin D may have untapped potential in fighting or preventing disease, suggests an explosion of new research. READ MORE>
AUGUST 2: URO TODAY: Some men in the control group (no testing) of the massive and important European Randomized study of Screening for Prostate Cancer appear to have contaminated the “study protocol” by getting themselves PSA tests, if an examination of what happened to 85,000 Frenchmen who participated is any indication. READ MORE>
AUGUST 2: URO TODAY: Genetic variation in a chromosome, 8q24, influences susceptibility to prostate cancer in men of European ancestry, a US study finds. READ MORE>
AUGUST 2: URO TODAY: Dairy food intake has been associated with prostate cancer in previous work, but the mechanism by which this occurs is unknown. READ MORE>
AUGUST 2: URO TODAY: French researchers have made a connection between pesticides and a high incidence of prostate cancer on the French Caribbean Island, Martinique. READ MORE>
AUGUST 1: PROSTABLOG NZ: The great Indian Ocean Rowing Race is finally over, with the last crew crossing the finishing line in Mauritius yesterday. READ MORE>
AUGUST 1: PROSTABLOG NZ: A new executive committee to run the Prostate Cancer Foundation of NZ (PCF) was elected by 50 PCF members at their annual meeting in Napier. READ MORE>
AUGUST 1: INSCIENCES.COM: Recently discovered nano-particles carrying killer genes have the potential to treat prostate cancer and viral infections, having already shown they can suppress ovarian cancer in mice. READ MORE>
AUGUST 1: ROCHESTER UNIVERSITY: Older people with cancer should be further classified or “staged” into subgroups based on other health issues they face, says a new study. READ MORE>
AUGUST 1: STAR-TRIBUNE.COM: A 58-year-old US male model claims he’s been defamed by an ad touting a prostate device that used his photo next to the words: “Now I can go like I am 19 again!” READ MORE>
AUGUST 1: NJ.COM: Some US hospitals are breaking ranks from their government’s lack of interest in prostate cancer screening and offering free tests to men. READ MORE>
AUGUST 1: NEW PROSTATE CANCER INFOLINK: The American Urological Association Foundation is developing a new “National Urology Research Agenda”. CLICK HERE> to take a poll on what prostate cancer treatment and research priorities should be.
AUGUST 1: URO TODAY: A study of 15 low-risk prostate cancer patients showed that radiation delivered with TomoTherapy better targets the tumour and spares the bladder and rectum, compared with static field intensity modulated radiation therapy (IMRT) and 3-dimensional conformal radiation therapy. READ MORE>
This is a very educational set of articles. I intend to refer my staff and patients here. Cancer can be overwhelming. I am glad to see some much needed education in this area.
Keith Barton D.Ir.
http://www.candidatherapythatworks.com